B. J. Kullberg and M. C. Arendrup, Invasive Candidiasis, N Engl J Med, vol.373, pp.1445-56, 2015.

H. Wisplinghoff, J. Ebbers, and L. Geurtz, Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities, International journal of antimicrobial agents, vol.43, pp.78-81, 2014.

P. Koehler, M. Stecher, and O. A. Cornely, Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2019.

O. Lortholary, C. Renaudat, and K. Sitbon, Worrisome trends in incidence and mortality of candidemia in intensive care units, Intensive care medicine, vol.40, pp.1303-1315, 2002.
URL : https://hal.archives-ouvertes.fr/pasteur-01405246

, healthcare facilities: global emergence of invasive infections caused by the multidrug-resistant yeast Candida auris, Atlanta: Centers for Disease Control and Prevention, 2017.

, Guidance for the laboratory investigation, management and infection prevention and control for cases of Candida auris, 2017.

, The Robert Koch Institute, Erhöhte Aufmerksamkeit bei Candida-auris-Fällen notwendig, vol.36, 2017.

, European Centre for Disease Prevention and Control. Candida auris in healthcare settingsEurope -first update, Stockholm: ECDC, 2018.

P. Mathur, F. Hasan, P. K. Singh, R. Malhotra, K. Walia et al., Five-year profile of candidaemia at an Indian trauma centre: High rates of Candida auris blood stream infections, Mycoses, vol.61, pp.674-80, 2018.

J. Rhodes, A. Abdolrasouli, and R. A. Farrer, Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris, Emerging microbes & infections, vol.7, p.43, 2018.

A. Ruiz-gaitan, A. M. Moret, and M. Tasias-pitarch, An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital, Mycoses, vol.61, pp.498-505, 2018.

S. Schelenz, F. Hagen, and J. L. Rhodes, First hospital outbreak of the globally emerging Candida auris in a European hospital, Antimicrobial resistance and infection control, vol.5, p.35, 2016.

F. Tissot, S. Agrawal, and L. Pagano, ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients, Haematologica, vol.102, pp.433-477, 2017.

A. J. Ullmann, M. Akova, and R. Herbrecht, ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT), Clinical Microbiology and Infectious Diseases, vol.18, pp.53-67, 2012.

M. Cuenca-estrella, P. E. Verweij, and M. C. Arendrup, ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clinical microbiology and infection : the official publication of the European Society of, Clinical Microbiology and Infectious Diseases, vol.18, pp.9-18, 2012.

O. A. Cornely, M. Bassetti, and T. Calandra, ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clinical microbiology and infection : the official publication of the European Society of, Clinical Microbiology and Infectious Diseases, vol.18, pp.19-37, 2012.

P. G. Pappas, C. A. Kauffman, and D. R. Andes, Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.62, pp.1-50, 2016.

S. C. Mellinghoff, M. Hoenigl, and P. Koehler, EQUAL Candida Score: An ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia Management, Mycoses, 2018.

S. B. Wey, M. Mori, M. A. Pfaller, R. F. Woolson, and R. P. Wenzel, Hospital-acquired candidemia. The attributable mortality and excess length of stay, Archives of internal medicine, vol.148, pp.2642-2647, 1988.

O. Gudlaugsson, S. Gillespie, and K. Lee, Attributable mortality of nosocomial candidemia, revisited, Clin Infect Dis, vol.37, pp.1172-1179, 2003.

M. Hoenigl, J. P. Gangneux, and E. Segal, Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together, Mycoses, vol.61, pp.885-94, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01863269

O. A. Cornely, C. Lass-florl, K. Lagrou, V. Arsic-arsenijevic, and M. Hoenigl, Improving outcome of fungal diseases -Guiding experts and patients towards excellence, Mycoses, vol.60, pp.420-425, 2017.

S. C. Mellinghoff, P. Hartmann, and F. B. Cornely, Analyzing candidemia guideline adherence identifies opportunities for antifungal stewardship, Eur J Clin Microbiol Infect Dis, 2018.

F. C. Koehler, O. A. Cornely, and H. Wisplinghoff, Candida-Reactive T Cells for the Diagnosis of Invasive Candida Infection-A Prospective Pilot Study, Front Microbiol, vol.9, pp.23-40, 2018.

L. Klingspor, A. M. Tortorano, and J. Peman, Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006-2008). Clinical microbiology and infection : the official publication of the, European Society of Clinical Microbiology and Infectious Diseases, vol.21, pp.1-10, 2015.

A. M. Tortorano, J. Peman, and H. Bernhardt, Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study, Eur J Clin Microbiol Infect Dis, vol.23, pp.317-339, 2004.

F. C. Koehler, O. A. Cornely, H. Wisplinghoff, D. H. Chang, A. Richter et al., Candida reactive T cells for the diagnosis of invasive Candida infection of the lumbar vertebral spine, 2017.

D. Seidel, L. A. Duran-graeff, and M. Vehreschild, FungiScope -Global Emerging Fungal Infection Registry, Mycoses, vol.60, pp.508-524, 2017.